Spatial Genomics and Transcriptomic Market Expected to Reach $2.15 Billion by 2030

According to a new report published by Allied Market Research, titled, “Spatial Genomics and Transcriptomic Market, by Technique, Product Type Application, End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global spatial genomics and transcriptomic market size was valued at $0.62 billion in 2020 and is projected to reach $2.15 billion by 2030 registering a CAGR of 13.6% from 2021 to 2030.

Spatial genomics & transcriptomic is a new discipline involving the identification of high-performance information concerning the organizational composition of tissue and cell content. It is a method that uses mRNA readouts to assign cell types to their positions in histological sections. This method may also be used to determine the subcellular localization and cellular heterogeneity of mRNA molecules in cancers and organs.

In addition, spatial genomics and transcriptomics provide information on immune cells and characterize the subcellular distribution of transcripts in a variety of situations. Spatial genomics has a lot of potential in disease control because it provides quantitative gene expression data as well as DNA and RNA visualization mapping into tissue components. In addition, sequencing techniques have a significant role in spatial transcriptomics, due to the widespread availability of sequencing platforms that aid in the study of RNA architecture in cells or tissues as well as the employment of advanced techniques inside a laboratory setup to investigate biological organisms.

The major factors that impact the growth of the spatial genomics and transcriptomic market include increase in adoption of spatial genomics and transcriptomics technologies, owing to their various applications. In addition, growth in prevalence of genetic disorders and applications of spatial genomics and transcriptomics in determination of disease and treatment markers also boost the growth of the market. Furthermore, rise in preference toward personalized medicines also fuels the growth of the market.

However, unavailability of skilled professionals and ethical & legal limitations associated with the use of spatial genomics and transcriptomic technologies hamper the growth of the market. On the other hand, growth in innovations in spatial genomics and transcriptomic technologies are expected to offer profitable opportunities for the growth of the market during the forecast period.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The global spatial genomics and transcriptomics market also declined in 2020 due to global economic recession led by COVID-19. However, market witness recovery in the year 2021, owing to increase in adoption of spatial genomics & transcriptomics to profile COVID-19 tissue autopsies as well as rise in biomarker identification and its use in drug discovery and development programs.

The global spatial genomics and transcriptomic market is segmented on the basis of technique, product type, application, end user, and region. By technique, it is bifurcated into spatial transcriptomics, and spatial genomics analysis. The spatial transcriptomics is further segmented into microdissection, fluorescent in-situ hybridization, in-situ sequencing, in-situ capturing, and in-silico construction. In addition, the spatial genomics analysis segment is segmented into, fluorescence in-situ sequencing, and fluorescence microscopy. The spatial genomics analysis segment was the major shareholder in 2020, owing to emerging potential of spatial genomic analysis as a cancer diagnostic tool, and advent of the fourth generation of sequencing.

By product type, it is segmented into instruments, consumables, and software. The consumables segment dominated the global spatial genomics and transcriptomic market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in adoption of consumables that are required to run the instruments across various stages of genome mapping from sample preparation to result derivation. Based on application, it is segmented into translational research, and drug discovery & development. The drug discovery & development acquired the largest share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in application of spatial genomic and transcriptomics technologies in drug discovery & development. By end user, it is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.

The academic & research institutes segment acquired the largest share in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to surge in genomic research projects conducted by academic research institutes as well as collaboration among major players and universities for development of novel approaches to cure chronic conditions through genetic medicine.

Key Findings Of The Study

• Based on technique, the spatial genomic analysis held largest share in the global market in 2020.
• Based on product type, the consumables held largest spatial genomics and transcriptomics market share in 2020 and is expected to remain dominant throughout the forecast period.
• By application, the drug discovery & development dominates the global spatial genomics and transcriptomic market in 2020 and is anticipated to continue this trend during the forecast period.
• By end user, the academic & research institutes held largest market share in 2020 and is anticipated to continue this trend during the forecast period.
• Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 10.6% during the forecast period.

North America accounted for the largest share of the global spatial genomics and transcriptomic market in 2020, and is expected to remain dominant throughout the forecast period. This was attributed to presence of large number of key players as well as increase in number of large-scale genomics studies leveraging RNA sequencing in the region. Furthermore, increasing adoption of personalized medicine for screening and diagnostics of genetic disorders is expected to further boost the market growth.